533 related articles for article (PubMed ID: 20152551)
1. Aripiprazole for the maintenance treatment of bipolar I disorder: A review.
McIntyre RS
Clin Ther; 2010; 32 Suppl 1():S32-8. PubMed ID: 20152551
[TBL] [Abstract][Full Text] [Related]
2. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
3. Double-blind, randomized, placebo-controlled long-term maintenance study of aripiprazole in children with bipolar disorder.
Findling RL; Youngstrom EA; McNamara NK; Stansbrey RJ; Wynbrandt JL; Adegbite C; Rowles BM; Demeter CA; Frazier TW; Calabrese JR
J Clin Psychiatry; 2012 Jan; 73(1):57-63. PubMed ID: 22152402
[TBL] [Abstract][Full Text] [Related]
4. Aripiprazole monotherapy in the treatment of acute bipolar I mania: a randomized, double-blind, placebo- and lithium-controlled study.
Keck PE; Orsulak PJ; Cutler AJ; Sanchez R; Torbeyns A; Marcus RN; McQuade RD; Carson WH;
J Affect Disord; 2009 Jan; 112(1-3):36-49. PubMed ID: 18835043
[TBL] [Abstract][Full Text] [Related]
5. Acute treatment of pediatric bipolar I disorder, manic or mixed episode, with aripiprazole: a randomized, double-blind, placebo-controlled study.
Findling RL; Nyilas M; Forbes RA; McQuade RD; Jin N; Iwamoto T; Ivanova S; Carson WH; Chang K
J Clin Psychiatry; 2009 Oct; 70(10):1441-51. PubMed ID: 19906348
[TBL] [Abstract][Full Text] [Related]
6. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: a 3-week placebo-controlled study.
Sachs G; Sanchez R; Marcus R; Stock E; McQuade R; Carson W; Abou-Gharbia N; Impellizzeri C; Kaplita S; Rollin L; Iwamoto T;
J Psychopharmacol; 2006 Jul; 20(4):536-46. PubMed ID: 16401666
[TBL] [Abstract][Full Text] [Related]
9. Aripiprazole monotherapy in nonpsychotic bipolar I depression: results of 2 randomized, placebo-controlled studies.
Thase ME; Jonas A; Khan A; Bowden CL; Wu X; McQuade RD; Carson WH; Marcus RN; Owen R
J Clin Psychopharmacol; 2008 Feb; 28(1):13-20. PubMed ID: 18204335
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of aripiprazole in subpopulations with acute manic or mixed episodes of bipolar I disorder.
Suppes T; Eudicone J; McQuade R; Pikalov A; Carlson B
J Affect Disord; 2008 Apr; 107(1-3):145-54. PubMed ID: 17904226
[TBL] [Abstract][Full Text] [Related]
11. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
[TBL] [Abstract][Full Text] [Related]
12. Aripiprazole in children and adolescents with bipolar disorder comorbid with attention-deficit/hyperactivity disorder: a pilot randomized clinical trial.
Tramontina S; Zeni CP; Ketzer CR; Pheula GF; Narvaez J; Rohde LA
J Clin Psychiatry; 2009 Apr; 70(5):756-64. PubMed ID: 19389329
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole for the treatment of pediatric bipolar I disorder: a 30-week, randomized, placebo-controlled study.
Findling RL; Correll CU; Nyilas M; Forbes RA; McQuade RD; Jin N; Ivanova S; Mankoski R; Carson WH; Carlson GA
Bipolar Disord; 2013 Mar; 15(2):138-49. PubMed ID: 23437959
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.
Keck PE; Calabrese JR; McIntyre RS; McQuade RD; Carson WH; Eudicone JM; Carlson BX; Marcus RN; Sanchez R;
J Clin Psychiatry; 2007 Oct; 68(10):1480-91. PubMed ID: 17960961
[TBL] [Abstract][Full Text] [Related]
15. Aripiprazole in major depression and mania: meta-analyses of randomized placebo-controlled trials.
Arbaizar B; Dierssen-Sotos T; Gómez-Acebo I; Llorca J
Gen Hosp Psychiatry; 2009; 31(5):478-83. PubMed ID: 19703642
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania.
Keck PE; Marcus R; Tourkodimitris S; Ali M; Liebeskind A; Saha A; Ingenito G;
Am J Psychiatry; 2003 Sep; 160(9):1651-8. PubMed ID: 12944341
[TBL] [Abstract][Full Text] [Related]
17. Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial.
Woo YS; Bahk WM; Chung MY; Kim DH; Yoon BH; Lee JH; Ahn YM; Chung SK; Kim JG; Lee KH; Paik KC
Hum Psychopharmacol; 2011 Dec; 26(8):543-53. PubMed ID: 22134973
[TBL] [Abstract][Full Text] [Related]
18. Management of acute agitation in patients with bipolar disorder: efficacy and safety of intramuscular aripiprazole.
Zimbroff DL; Marcus RN; Manos G; Stock E; McQuade RD; Auby P; Oren DA
J Clin Psychopharmacol; 2007 Apr; 27(2):171-6. PubMed ID: 17414241
[TBL] [Abstract][Full Text] [Related]
19. Young mania rating scale line item analysis in pediatric subjects with bipolar I disorder treated with aripiprazole in a short-term, double-blind, randomized study.
Mankoski R; Zhao J; Carson WH; Mathew SJ; Forbes RA
J Child Adolesc Psychopharmacol; 2011 Aug; 21(4):359-64. PubMed ID: 21823911
[TBL] [Abstract][Full Text] [Related]
20. A UK panel consensus on the initiation of aripiprazole for the treatment of bipolar mania.
Dratcu L; Bobmanuel S; Davies W; Farmer A; George M; Rana T; Singh M; Turner M
Int J Psychiatry Clin Pract; 2012 Oct; 16(4):244-58. PubMed ID: 22809129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]